RP-A501 Breaking News QuidelOrtho Q4 Revenues Dip 5 Percent, Beat Estimates 10x Genomics Q4 Revenues Fall 10 Percent, In Line With Preliminary Estimates Grail Stock Surges on Quest Diagnostics Integration of Galleri MCED Test Cell-Free DNA Analysis Predicts Preeclampsia Risk Waters Q4 Revenues Rise 6 Percent